— Know what they know.
Not Investment Advice

IRIX NASDAQ

IRIDEX Corporation
1W: +2.9% 1M: -10.8% 3M: -42.6% YTD: -45.0% 1Y: -43.1% 3Y: -69.5% 5Y: -91.4%
$0.64
+0.01 (+1.77%)
 
Weekly Expected Move ±5.8%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 32 · $11.1M mcap · 11M float · 0.618% daily turnover · Short 31% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$53M +8.2% ▲
5Y CAGR: +7.7%
Gross Profit
$19M -1.0% ▼
5Y CAGR: +4.4%
Operating Income
-$3M +69.0% ▲
Net Income
-$4M +50.2% ▲
EPS (Diluted)
$-0.26 +51.9% ▲
EBITDA
-$1M +85.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$54M$57M$52M$49M$53M
YoY Growth+48.3%+5.7%-9.0%-6.2%+8.2%
Cost of Revenue$31M$32M$30M$29M$33M
Gross Profit$23M$25M$22M$20M$19M
Gross Margin42.4%44.5%42.0%40.1%36.7%
R&D Expenses$7M$7M$7M$5M$4M
SG&A Expenses$23M$26M$25M$22M$18M
Operating Expenses$30M$33M$32M$28M$22M
Operating Income-$8M-$8M-$10M-$8M-$3M
Operating Margin-14.0%-13.2%-19.3%-17.1%-4.9%
Interest Expense$0$0$0$0$0
Income Before Tax-$5M-$7M-$9M-$9M-$4M
Tax Expense$40K$65K$90K$68K$57K
Net Income-$5M-$8M-$10M-$9M-$4M
Net Margin-9.7%-13.2%-18.5%-18.3%-8.4%
EPS (Diluted)$-0.34$-0.47$-0.59$-0.54$-0.26
EBITDA-$7M-$6M-$8M-$7M-$1M
Shares Outstanding15M16M16M16M17M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms